Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Pacira BioSciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Charles River Laboratories International Inc. May 5, 202681.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 21, 2026 | Rapport Therapeutics Inc. | Open-market sale | −2,210 | $29.16 | $64,448 |
| Oct 7, 2026 | Rapport Therapeutics Inc. | Open-market sale | −1,147 | $30.66 | $35,167 |
| Oct 6, 2026 | Rapport Therapeutics Inc. | Open-market sale | −3,375 | $32.03 | $108,106 |
| Sep 23, 2026 | Rapport Therapeutics Inc. | Open-market sale | −1,952 | $39.05 | $76,226 |
| Sep 23, 2026 | Rapport Therapeutics Inc. | Open-market sale | −215 | $39.86 | $8,570 |
| Sep 23, 2026 | Rapport Therapeutics Inc. | Open-market sale | −43 | $41.05 | $1,765 |
| Sep 8, 2026 | Rapport Therapeutics Inc. | Open-market sale | −7,141 | $45.56 | $325,344 |
| Sep 8, 2026 | Rapport Therapeutics Inc. | Open-market sale | −1,069 | $46.01 | $49,185 |
| Aug 25, 2026 | Rapport Therapeutics Inc. | Open-market sale | −18,921 | $49.57 | $937,914 |
| Aug 11, 2026 | Rapport Therapeutics Inc. | Open-market sale | −3,664 | $46.90 | $171,842 |
| Aug 11, 2026 | Rapport Therapeutics Inc. | Open-market sale | −19,500 | $48.04 | $936,780 |
| Aug 11, 2026 | Rapport Therapeutics Inc. | Open-market sale | −5,794 | $48.62 | $281,704 |
| Aug 10, 2026 | Rapport Therapeutics Inc. | Open-market sale | −14,171 | $45.97 | $651,441 |
| Aug 10, 2026 | Rapport Therapeutics Inc. | Open-market sale | −8,370 | $46.75 | $391,298 |
| Jul 27, 2026 | Rapport Therapeutics Inc. | Open-market sale | −2,203 | $42.11 | $92,768 |
Questions about Abraham Ceesay
What boards is Abraham Ceesay on?
Abraham Ceesay sits on the boards of Charles River Laboratories International Inc., Pacira BioSciences Inc. and Rapport Therapeutics Inc.
What company is Abraham Ceesay the CEO of?
Abraham Ceesay has been Chief Executive Officer of Rapport Therapeutics Inc. since June 2024.
How long has Abraham Ceesay served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.